Indlægsseddel: Information til brugeren Buprenorphine Teva 5 mikrogram/time depotplastre Buprenorphine Teva 10 mikrogram/time d
![These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-24.jpg&id=607115)
These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval:
Buprenorphine "Teva" Teva B.V. depotplastre 5 mikrogram/time, 10 mikrogram/time og 20 mikrogram/time
1 LÄKEMEDLETS NAMN 2 KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING 3 LÄKEMEDELSFORM 4 KLINISKA UPPGIFTER
![These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-7.jpg&id=651563)